These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38010458)

  • 1. Benefits and Harms of Mammography Screening in 75 + Women to Inform Shared Decision-making: a Simulation Modeling Study.
    Jayasekera J; Stein S; Wilson OWA; Wojcik KM; Kamil D; Røssell EL; Abraham LA; O'Meara ES; Schoenborn NL; Schechter CB; Mandelblatt JS; Schonberg MA; Stout NK
    J Gen Intern Med; 2024 Feb; 39(3):428-439. PubMed ID: 38010458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
    Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
    Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
    Miglioretti DL; Lange J; van den Broek JJ; Lee CI; van Ravesteyn NT; Ritley D; Kerlikowske K; Fenton JJ; Melnikow J; de Koning HJ; Hubbard RA
    Ann Intern Med; 2016 Feb; 164(4):205-14. PubMed ID: 26756460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
    Schousboe JT; Kerlikowske K; Loh A; Cummings SR
    Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
    Trentham-Dietz A; Chapman CH; Jayasekera J; Lowry KP; Heckman-Stoddard BM; Hampton JM; Caswell-Jin JL; Gangnon RE; Lu Y; Huang H; Stein S; Sun L; Gil Quessep EJ; Yang Y; Lu Y; Song J; Muñoz DF; Li Y; Kurian AW; Kerlikowske K; O'Meara ES; Sprague BL; Tosteson ANA; Feuer EJ; Berry D; Plevritis SK; Huang X; de Koning HJ; van Ravesteyn NT; Lee SJ; Alagoz O; Schechter CB; Stout NK; Miglioretti DL; Mandelblatt JS
    JAMA; 2024 Jun; 331(22):1947-1960. PubMed ID: 38687505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
    Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
    Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study.
    Alagoz O; Hajjar A; Chootipongchaivat S; van Ravesteyn NT; Yeh JM; Ergun MA; de Koning HJ; Chicoine B; Martin B
    J Gen Intern Med; 2019 Nov; 34(11):2374-2381. PubMed ID: 31385214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.
    Stout NK; Lee SJ; Schechter CB; Kerlikowske K; Alagoz O; Berry D; Buist DS; Cevik M; Chisholm G; de Koning HJ; Huang H; Hubbard RA; Miglioretti DL; Munsell MF; Trentham-Dietz A; van Ravesteyn NT; Tosteson AN; Mandelblatt JS
    J Natl Cancer Inst; 2014 Jun; 106(6):dju092. PubMed ID: 24872543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women.
    van Ravesteyn NT; Schechter CB; Hampton JM; Alagoz O; van den Broek JJ; Kerlikowske K; Mandelblatt JS; Miglioretti DL; Sprague BL; Stout NK; de Koning HJ; Trentham-Dietz A; Tosteson ANA;
    J Natl Cancer Inst; 2021 Aug; 113(8):1017-1026. PubMed ID: 33515225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
    Glechner A; Wagner G; Mitus JW; Teufer B; Klerings I; Böck N; Grillich L; Berzaczy D; Helbich TH; Gartlehner G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009632. PubMed ID: 36999589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Siu AL;
    Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
    Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
    Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History.
    van den Broek JJ; Schechter CB; van Ravesteyn NT; Janssens ACJW; Wolfson MC; Trentham-Dietz A; Simard J; Easton DF; Mandelblatt JS; Kraft P; de Koning HJ
    J Natl Cancer Inst; 2021 Apr; 113(4):434-442. PubMed ID: 32853342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
    Lowry KP; Geuzinge HA; Stout NK; Alagoz O; Hampton J; Kerlikowske K; de Koning HJ; Miglioretti DL; van Ravesteyn NT; Schechter C; Sprague BL; Tosteson ANA; Trentham-Dietz A; Weaver D; Yaffe MJ; Yeh JM; Couch FJ; Hu C; Kraft P; Polley EC; Mandelblatt JS; Kurian AW; Robson ME;
    JAMA Oncol; 2022 Apr; 8(4):587-596. PubMed ID: 35175286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care.
    Pillay J; Guitard S; Rahman S; Saba S; Rahman A; Bialy L; Gehring N; Tan M; Melton A; Hartling L
    Syst Rev; 2024 May; 13(1):140. PubMed ID: 38807191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Equitable Screening Mammography Strategies for Black Women in the United States Using Simulation Modeling.
    Chapman CH; Schechter CB; Cadham CJ; Trentham-Dietz A; Gangnon RE; Jagsi R; Mandelblatt JS
    Ann Intern Med; 2021 Dec; 174(12):1637-1646. PubMed ID: 34662151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.
    van Ravesteyn NT; Stout NK; Schechter CB; Heijnsdijk EA; Alagoz O; Trentham-Dietz A; Mandelblatt JS; de Koning HJ
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25948872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.